Medicine
Tikosyn 0.25 mg capsule
Tikosyn 0.25 mg capsule is a prescription medicine containing Dofetilide for oral use, marketed by Pfizer Laboratories, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at controlled room temperature, 15° to 30°C (59° to 86°F). PROTECT FROM…
Key facts
- Active ingredient (INN)
- Dofetilide
- Brand
- Tikosyn
- Strength
- 0.25 mg
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 60 capsules, 14 capsules
- Marketing authorisation holder
- Pfizer Laboratories
- Manufacturer
- Pfizer Laboratories
- Origin register
- US FDA, United States
- Storage
- Store at controlled room temperature, 15° to 30°C (59° to 86°F). PROTECT FROM MOISTURE AND HUMIDITY.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C01BD04 Dofetilide
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 October 1999
- Identifiers
- RxCUI 284404, 284405, 285016 +3DailyMed set ID 02438044-d6a3-49e9-a1ac-3aad21ef2c8cNDC 0069-5810Application NDA020931
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 60 capsule in 1 bottle | 0069-5810-60 | Pfizer Laboratories | 1 October 1999 |
| 14 capsule in 1 bottle | 0069-5810-61 | Pfizer Laboratories | 1 October 1999 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Dofetilide 0.25 mg capsule.
Other strengths and forms of Dofetilide
Clinical summary
Dofetilide is an antiarrhythmic indicated for the maintenance of normal sinus rhythm (delay in time to recurrence of atrial fibrillation/atrial flutter [AF/AFl]) in patients with atrial fibrillation/atrial flutter of greater than one week duration. MedsAcross supplies Dofetilide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about DofetilideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Tikosyn prescribing information (Pfizer Laboratories) · U.S. National Library of Medicine, DailyMed
Need Tikosyn 0.25 mg capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.